Why Bayer (BAYRY) Stock Is Higher This Morning

NEW YORK (TheStreet) -- Shares of Bayer AG (BAYRY) are higher by 3.94% to $135.20 after it was reported that the pharmaceutical and chemicals company is exploring a sale of its $10 billion plastics unit to focus on expanding the health business, sources say, according to Bloomberg.

The German company is considering the options for Bayer Material Science after Evonik Industries AG showed potential interest several months ago, sources added.

No final decision has been made on the plastics unit, and the Evonik considerations failed to gain traction, they said, Bloomberg noted.

Also, Bayer first quarter earnings before interest, taxes, depreciation, amortization and special items jumped to 2.74 billion euros, beating the 2.56 billion-euro average estimate compiled by Bloomberg.

Must Read: Warren Buffett's 10 Favorite Growth Stocks

BAYRY Chart

BAYRY data by YCharts

STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks that can potentially TRIPLE in the next 12-months.Learn more.

If you liked this article you might like

Why Thousands Will Attend ASH Hematology Conference in Atlanta This Weekend

Why Thousands Will Attend ASH Hematology Conference in Atlanta This Weekend

Bayer Falls After Health Care and Pharma Results Disappoint

Bayer Falls After Health Care and Pharma Results Disappoint

European Markets Mixed Ahead of ECB Meeting

European Markets Mixed Ahead of ECB Meeting

Covestro Leaps On Surprise Share Buy Back and Massive Earnings Beat

Covestro Leaps On Surprise Share Buy Back and Massive Earnings Beat

BASF Agrees to Purchase Bayer's Herbicide Division for €6 Billion

BASF Agrees to Purchase Bayer's Herbicide Division for €6 Billion